Cite
Moyes KW, Davis A, Hoglund V, et al. Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma. Oncoimmunology. 2018;7(11):e1507668doi: 10.1080/2162402X.2018.1507668.
Moyes, K. W., Davis, A., Hoglund, V., Haberthur, K., Lieberman, N. A., Kreuser, S. A., Deutsch, G. H., Franco, S., Locke, D., Carleton, M. O., Gilbertson, D. G., Simmons, R., Winter, C., Silber, J., Gonzalez-Cuyar, L. F., Ellenbogen, R. G., & Crane, C. A. (2018). Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma. Oncoimmunology, 7(11), e1507668. https://doi.org/10.1080/2162402X.2018.1507668
Moyes, Kara W, et al. "Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma." Oncoimmunology vol. 7,11 (2018): e1507668. doi: https://doi.org/10.1080/2162402X.2018.1507668
Moyes KW, Davis A, Hoglund V, Haberthur K, Lieberman NA, Kreuser SA, Deutsch GH, Franco S, Locke D, Carleton MO, Gilbertson DG, Simmons R, Winter C, Silber J, Gonzalez-Cuyar LF, Ellenbogen RG, Crane CA. Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma. Oncoimmunology. 2018 Aug 27;7(11):e1507668. doi: 10.1080/2162402X.2018.1507668. eCollection 2018. PMID: 30377570; PMCID: PMC6204983.
Copy
Download .nbib